Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
6.53
+0.13 (2.03%)
Oct 14, 2025, 3:28 PM EDT - Market open
Generation Bio Co. Stock Forecast
Stock Price Forecast
The 3 analysts that cover Generation Bio Co. stock have a consensus rating of "Buy" and an average price target of $10.67, which forecasts a 63.40% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $15.
Price Target: $10.67 (+63.40%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 18, 2025.
Analyst Ratings
The average analyst rating for Generation Bio Co. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +53.14% | Aug 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +129.71% | Aug 13, 2025 |
| Wedbush | Wedbush | Buy → Hold Downgrades $7 | Buy → Hold | Downgrades | $7 | +7.20% | Aug 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +1,125.11% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +1,125.11% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
10.79M
from 19.89M
Decreased by -45.76%
Revenue Next Year
6.32M
from 10.79M
Decreased by -41.39%
EPS This Year
-12.39
from -19.76
EPS Next Year
-3.71
from -12.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.6M | 20.5M | |||
| Avg | 10.8M | 6.3M | |||
| Low | 9.3M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -36.7% | 89.7% | |||
| Avg | -45.8% | -41.4% | |||
| Low | -53.3% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -9.49 | -1.13 | |
| Avg | -12.39 | -3.71 | |
| Low | -15.11 | -11.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.